Page last updated: 2024-09-03

23-seleno-25-homotaurocholic acid and Bile Duct Obstruction

23-seleno-25-homotaurocholic acid has been researched along with Bile Duct Obstruction in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Merrick, MV; Ross, HM; Simpson, JD; Soundy, RG1
Chazouillères, O; Haniche, M; Jian, R; Marteau, P; Poupon, R1

Trials

1 trial(s) available for 23-seleno-25-homotaurocholic acid and Bile Duct Obstruction

ArticleYear
Ileal absorption of bile acids in patients with chronic cholestasis: SeHCAT test results and effect of ursodeoxycholic acid (UDCA).
    Digestive diseases and sciences, 1996, Volume: 41, Issue:12

    Topics: Alkaline Phosphatase; Bile Acids and Salts; Cholestasis; Chronic Disease; Down-Regulation; Female; gamma-Glutamyltransferase; Humans; Ileum; Intestinal Absorption; Liver Cirrhosis; Male; Middle Aged; Selenium Radioisotopes; Taurocholic Acid; Up-Regulation; Ursodeoxycholic Acid

1996

Other Studies

1 other study(ies) available for 23-seleno-25-homotaurocholic acid and Bile Duct Obstruction

ArticleYear
Absorbed dose to man from the Se-75 labeled conjugated bile salt SeHCAT: concise communication.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1982, Volume: 23, Issue:2

    Topics: Administration, Oral; Animals; Body Burden; Cholestasis; Energy Transfer; Gallbladder; Humans; Injections, Intravenous; Mice; Radiation Dosage; Radioisotopes; Rats; Selenium; Taurocholic Acid; Time Factors; Tissue Distribution; Whole-Body Counting

1982